Related Experiment Videos
Intensive insulin regimens: evidence for benefit
1Third Medical Department and Policlinic, University Hospital Giessen, Giessen, Germany. reinhard.bretzel@innere.med.uni-giessen.de
Summary
Intensive insulin therapy improves glycemic control, reducing microvascular complications in diabetes. It may also benefit macrovascular outcomes, offering better overall prognosis for diabetic patients.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Management
Background:
- Diabetic complications are linked to glycemic control.
- Intensive insulin regimens reduce microvascular risks (retinopathy, nephropathy, neuropathy) in Type I and II diabetes.
- Past glycemic exposure influences microvascular complication risk.
Purpose of the Study:
- To assess the impact of intensive insulin regimens on both microvascular and macrovascular complications in diabetes.
- To explore the role of fasting and postprandial glucose control in cardiovascular outcomes.
- To evaluate intensive insulin therapy's effect on prognosis in acute cardiovascular events.
Main Methods:
- Review of clinical trials (DCCT, Kumamoto, EDIC) and epidemiological data.
- Analysis of intensive insulin regimens focusing on glycemic control (fasting and postprandial).
- Examination of outcomes related to microvascular and macrovascular complications, including cardiovascular events.
Main Results:
- Intensive insulin therapy effectively reduces microvascular complications.
- Data on macrovascular risk reduction with intensive insulin regimens is inconclusive but suggests potential benefits.
- Controlling both fasting and postprandial glucose may improve macrovascular outcomes.
- Intensive insulin treatment improves prognosis in myocardial infarction.
Conclusions:
- Intensive insulin regimens achieve strict metabolic control in diabetes.
- These regimens offer potential for optimal outcomes regarding both microvascular and macrovascular complications.
- Further research is needed to confirm macrovascular benefits.